E2F1‐mediated transcriptional inhibition of the plasminogen activator inhibitor type 1 gene

作者: Magdalena Koziczak , Heiko Müller , Kristian Helin , Yoshikuni Nagamine

DOI: 10.1046/J.0014-2956.2001.02428.X

关键词:

摘要: 1Gene expression of the plasminogen activation system is cell-cycle dependent. Previously, we showed that ectopic E2F1 repressed activator inhibitor type 1 (PAI-1) promoter in a manner dependent on presence DNA-binding and transactivation domains but independent binding to pocket-binding proteins, suggesting novel mechanism for E2F-mediated negative gene regulation [Koziczak, M., Krek, W. & Nagamine, Y. (2000) Mol. Cell. Biol.20, 2014–2022]. However, it remains be seen whether endogenous E2F can exert similar effect. We report here down-regulation PAI-1 correlates with an increase activity. When cells were treated cdk2/4-specific inhibitor, which maintains inactive state, decline serum-induced mRNA levels was suppressed. In mutant U2OS expressing temperature-sensitive retinoblastoma protein (pRB), shift permissive temperature induced expression. stably E2F1-estrogen receptor chimeric could activated by tamoxifen, transcription markedly reduced tamoxifen even cycloheximide. These results all indicate directly repress gene. DNase I hypersensitive-site analysis suggested involvement conformation changes chromatin structure promoter. 5′ deletion multiple sites responsible regulation, some Interestingly, one these p53-binding element.

参考文章(64)
J R Nevins, Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth & Differentiation. ,vol. 9, pp. 585- 593 ,(1998)
D. J. O'Connor, E. W. Lam, S. Griffin, S. Zhong, L. C. Leighton, S. A. Burbidge, X. Lu, Physical and functional interactions between p53 and cell cycle co-operating transcription factors, E2F1 and DP1. The EMBO Journal. ,vol. 14, pp. 6184- 6192 ,(1995) , 10.1002/J.1460-2075.1995.TB00309.X
D. L. Herrin, G. W. Schmidt, Rapid, reversible staining of northern blots prior to hybridization. BioTechniques. ,vol. 6, pp. 196- ,(1988)
A. Ziegler, J. Knesel, D. Fabbro, Y. Nagamine, Protein kinase C down-regulation enhances cAMP-mediated induction of urokinase-type plasminogen activator mRNA in LLC-PK1 cells. Journal of Biological Chemistry. ,vol. 266, pp. 21067- 21074 ,(1991) , 10.1016/S0021-9258(18)54821-3
Keith D. Robertson, Slimane Ait-Si-Ali, Tomoki Yokochi, Paul A. Wade, Peter L. Jones, Alan P. Wolffe, DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters Nature Genetics. ,vol. 25, pp. 338- 342 ,(2000) , 10.1038/77124
M Yoshida, M Kijima, M Akita, T Beppu, Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. Journal of Biological Chemistry. ,vol. 265, pp. 17174- 17179 ,(1990) , 10.1016/S0021-9258(17)44885-X
V Ellis, M F Scully, V V Kakkar, Plasminogen Activation Initiated by Single-chain Urokinase-type Plasminogen Activator Journal of Biological Chemistry. ,vol. 264, pp. 2185- 2188 ,(1989) , 10.1016/S0021-9258(18)94159-1
L Andrus, M S Altus, D Pearson, M Grattan, Y Nagamine, hsp70 mRNA accumulates in LLC-PK1 pig kidney cells treated with calcitonin but not with 8-bromo-cyclic AMP. Journal of Biological Chemistry. ,vol. 263, pp. 6183- 6187 ,(1988) , 10.1016/S0021-9258(18)68769-1